| scholarly article | Q13442814 |
| P50 | author | Joanne Kurtzberg | Q89893926 |
| Shelly L Carter | Q123668394 | ||
| P2093 | author name string | Yanli Wang | |
| John E Wagner | |||
| David Margolis | |||
| Mary M Horowitz | |||
| Michael R Verneris | |||
| Colleen Delaney | |||
| Mark Walters | |||
| Donna A Wall | |||
| Nancy Bunin | |||
| Mary Eapen | |||
| Kirk R Schultz | |||
| Edward Peres | |||
| Blood and Marrow Transplant Clinical Trials Network | |||
| Paul Haut | |||
| P2860 | cites work | Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia | Q30415126 |
| Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival | Q34144410 | ||
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| Umbilical cord blood transplantation: the first 25 years and beyond | Q34344669 | ||
| Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies | Q35083562 | ||
| Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review | Q35204062 | ||
| Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease | Q36059652 | ||
| Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations | Q36794125 | ||
| Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities | Q36936090 | ||
| Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies | Q36969812 | ||
| Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors | Q37129657 | ||
| Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units | Q37414733 | ||
| Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood | Q37435417 | ||
| Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France | Q37618923 | ||
| Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. | Q37788411 | ||
| An overview of the progress on double umbilical cord blood transplantation. | Q37872506 | ||
| 1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
| Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia | Q44499780 | ||
| Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease | Q45232862 | ||
| Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of E | Q46788345 | ||
| Non-parametric inference for cumulative incidence functions in competing risks studies. | Q52266832 | ||
| Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy | Q56777948 | ||
| Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients | Q71133353 | ||
| Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity | Q73052921 | ||
| Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group | Q73552614 | ||
| Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors | Q74022952 | ||
| Outcomes among 562 recipients of placental-blood transplants from unrelated donors | Q77598678 | ||
| Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT) | Q81342166 | ||
| Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants | Q83322928 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1685-1694 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | One-unit versus two-unit cord-blood transplantation for hematologic cancers | |
| P478 | volume | 371 |
| Q33722088 | A History of Cord Blood Banking and Transplantation |
| Q39031937 | A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database |
| Q48134193 | A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. |
| Q64262035 | Adaptive NK cell reconstitution is associated with better clinical outcomes |
| Q38734758 | Advances in umbilical cord blood cell therapy: the present and the future |
| Q26824305 | Advances in umbilical cord blood manipulation-from niche to bedside |
| Q38721768 | Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. |
| Q30252339 | Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017! |
| Q26799456 | Alternative Donor Transplantation for Acute Myeloid Leukemia |
| Q38350274 | Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors? |
| Q93062728 | Alternative donors: a match for matched sibling donors? |
| Q36157327 | Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation |
| Q36115699 | Better allele-level matching improves transplant-related mortality after double cord blood transplantation. |
| Q64104503 | CD34 cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking |
| Q38586429 | Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients |
| Q39147431 | Clinical Studies in Hematologic Microtransplantation |
| Q38619234 | Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases |
| Q52730545 | Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. |
| Q33822026 | Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. |
| Q38696346 | Cord blood transplant for acute myeloid leukaemia |
| Q61052946 | Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4 T-cell reconstitution |
| Q38780874 | Cord blood transplantation: rewind to fast forward |
| Q51003420 | Cryopreservation of cord blood CD34+ cells before or after thrombopoietin expansion differentially affects early platelet recovery in NOD SCID mice. |
| Q36897147 | Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay |
| Q46390290 | Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation. |
| Q50660084 | Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation |
| Q47195077 | Double vs. single cord blood transplantation in adolescent and adult hematological malignancies with heavier body weight (≥50 kg). |
| Q33882309 | Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors |
| Q41829687 | Endothelium-targeted human Delta-like 1 enhances the regeneration and homing of human cord blood stem and progenitor cells |
| Q47230830 | Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling. |
| Q88375312 | Epidemiologic Profile of Patients Transplanted With Hematopoietic Stem Cells in a Reference Service in the State of Rio Grande do Norte, Brazil |
| Q47384522 | Evaluation of the impact of banking umbilical cord blood units with high cell dose for ethnically diverse patients |
| Q50704219 | Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission. |
| Q36176911 | From evidence to clinical practice in blood and marrow transplantation |
| Q33766984 | From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation |
| Q64067194 | GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia |
| Q48324190 | Going home for the holidays? Take a shortcut! |
| Q39368481 | Graft predominance after double umbilical cord blood transplantation: a review |
| Q38851953 | Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches |
| Q26771763 | Hematopoietic stem cell expansion and generation: the ways to make a breakthrough |
| Q91195058 | Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study |
| Q92437782 | Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT |
| Q51233371 | Human umbilical cord blood hematopoietic stem cell expansion by the RNA-binding protein Musashi-2. |
| Q38728525 | Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly. |
| Q36578783 | Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation |
| Q39865680 | Impact of early CMV reactivation in cord blood stem cell recipients in the current era. |
| Q40472138 | Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children: A Single-Center Experience From Hong Kong. |
| Q28066500 | Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors |
| Q40012419 | Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment |
| Q91556007 | Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study |
| Q26770210 | Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants? |
| Q38658670 | Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications |
| Q28067102 | Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments |
| Q37197917 | Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation |
| Q39031745 | Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy |
| Q52804927 | One or two umbilical cord blood cell units? Caveat emptor. |
| Q38747929 | Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies |
| Q93062722 | Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis |
| Q55331096 | Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol. |
| Q64976532 | Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide. |
| Q36938847 | Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft |
| Q38743140 | Phase II study of intrabone single unit cord blood transplantation for hematological malignancies |
| Q88797034 | Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection |
| Q92603384 | Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study |
| Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
| Q91907337 | Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantation |
| Q36675937 | Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors |
| Q91774665 | Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR |
| Q89777011 | Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia |
| Q33820379 | Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT |
| Q53256317 | Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells. |
| Q26740251 | The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation |
| Q33816017 | The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia |
| Q64070310 | The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia |
| Q34483172 | The role and potential of umbilical cord blood in an era of new therapies: a review |
| Q49617833 | The role of policies and networks in development of cord blood usage in China |
| Q52819128 | UK experience of unrelated cord blood transplantation in paediatric patients. |
| Q46093492 | Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes |
| Q30352323 | Umbilical Cord Blood Transplantation: Challenges and Future Directions. |
| Q38510475 | Umbilical cord blood donation: public or private? |
| Q47569026 | Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord |
| Q61803898 | Unrelated cord blood transplantation and post-transplant cyclophosphamide |
| Q98386101 | Unrelated cord blood transplantation with myeloablative conditioning for pediatric acute lymphoblastic leukemia in remission: prognostic factors |
| Q41589103 | Update on umbilical cord blood transplantation |
Search more.